| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/03/2023 | 2012.68% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 10/25/2021 | 2012.68% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
What is the target price for Biophytis (BPTS)?
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on February 3, 2023. The analyst firm set a price target for $15.00 expecting BPTS to rise to within 12 months (a possible 2012.68% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biophytis (BPTS)?
The latest analyst rating for Biophytis (NASDAQ: BPTS) was provided by HC Wainwright & Co., and Biophytis reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Biophytis (BPTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biophytis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biophytis was filed on February 3, 2023 so you should expect the next rating to be made available sometime around February 3, 2024.
Is the Analyst Rating Biophytis (BPTS) correct?
While ratings are subjective and will change, the latest Biophytis (BPTS) rating was a reiterated with a price target of $0.00 to $15.00. The current price Biophytis (BPTS) is trading at is $0.71, which is within the analyst's predicted range.